Fox Chase Researchers Use Liquid Biopsies to Study Genetic Variants in Tumors for Potential Therapies in Breast Cancer
PHILADELPHIA (November 18, 2021)—In a recent study using liquid biopsies and tumor tissue biomarkers, researchers at Fox Chase Cancer Center found that PARP inhibitors and PD-1/PDL1 blocking immunotherapy could be considered an effective treatment in eligible inflammatory breast cancer patients.